Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Terrance McGuire Other companies: Tectonic Therapeutic, Inc. (Director · Since at least Jun 20, 2024); Invivyd, Inc. (Director · Since at least Aug 5, 2021); Seer, Inc. (Director · Since at least Dec 3, 2020); Alector, Inc. (Director · Feb 6, 2019 – Sep 11, 2023 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past); Pulmatrix, Inc. (Director · Jun 15, 2015 – May 16, 2019 · Past); Trevena, Inc. (Director · Jan 30, 2014 – May 14, 2014 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Mar 2, 2017 · Past); Ironwood Pharmaceuticals, Inc. (Director · Jun 3, 2013 – Apr 1, 2019 · Past) | Director · Apr 1, 2019 – Nov 30, 2023 · Past |
| Tomas Kiselak Other companies: Crescent Biopharma, Inc. (Director · Since at least Jun 13, 2025); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Spyre Therapeutics, Inc. (Director · Since at least Jun 22, 2023); Viridian Therapeutics, Inc. (Director · Since at least Oct 27, 2020); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – Sep 27, 2024 · Past) | Chairman · Since at least Apr 1, 2026 |
| Amy Schulman Other companies: Elevance Health, Inc. (Director · Since at least Dec 10, 2025); Fractyl Health, Inc. (Director · Since at least Feb 1, 2024); Alnylam Pharmaceuticals, Inc. (Director · Since at least Jun 20, 2018); Hudson Executive Investment Corp II (Director · Jan 25, 2021 – Apr 13, 2021 · Past); Ironwood Pharmaceuticals, Inc. (Director · May 31, 2018 – Apr 1, 2019 · Past); Blue Buffalo Pet Products Inc (Director · Apr 24, 2018 – Apr 24, 2018 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past) | Director · Apr 1, 2019 – Jun 16, 2020 · Past |
| Marsha Fanucci Other companies: Generate Biomedicines, Inc. (Director · Since at least Feb 26, 2026); Forma Therapeutics Holdings Inc (Director · Jun 18, 2020 – Oct 14, 2022 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 29, 2016 – Jun 5, 2024 · Past); Alnylam Pharmaceuticals, Inc. (Director · Dec 8, 2010 – May 18, 2023 · Past); Ironwood Pharmaceuticals, Inc. (Director · Feb 2, 2010 – Apr 1, 2019 · Past); Momenta Pharmaceuticals Inc (Director · Jun 15, 2006 – Jun 23, 2016 · Past); Millennium Pharmaceuticals Inc (SVP, Chief Financial Officer · Sep 15, 2005 – May 14, 2008 · Past) | Director · Mar 14, 2019 – Jun 14, 2022 · Past |
| Jonathan Violin Other companies: Crescent Biopharma, Inc. (Director · Since at least Jun 13, 2025); Dianthus Therapeutics, Inc. (Director · Since at least Sep 11, 2023); Astria Therapeutics Inc (Director · Since at least Jan 28, 2021); Viridian Therapeutics, Inc. (Chief Executive Officer, Director · Oct 27, 2020 – Feb 2, 2023 · Past); Trevena, Inc. (SVP-Scientific Affairs & IR · Jan 29, 2018 – Feb 28, 2018 · Past) | Chief Executive Officer · Since at least Apr 1, 2026 |
| Michael J. Higgins Other companies: CAMP4 Therapeutics Corporation (Director · Since at least Oct 10, 2024); Voyager Therapeutics, Inc. (Chair · Since at least Nov 10, 2015); Pulmatrix, Inc. (Chairman of the PULMATRiX Board of Directors · Since at least Jun 15, 2015); Ironwood Pharmaceuticals, Inc. (Chief Operating Officer · Feb 2, 2010 – Dec 23, 2014 · Past) | Director · Nov 30, 2023 – Mar 25, 2025 · Past |
| Christopher Wright Other companies: Wave Life Sciences Ltd. (Chief Medical Officer · Since at least May 28, 2025); Alkermes plc (Director · Since at least May 24, 2022) | Chief Medical Officer · Feb 25, 2021 – Feb 25, 2021 · Past |
| Errol B Desouza Other companies: Alector, Inc. (Director · Since at least Mar 19, 2024); Royalty Pharma plc (Director · Jun 7, 2024 – May 13, 2025 · Past) | Director · Nov 30, 2023 – Nov 30, 2023 · Past |
| George H Conrades Other companies: Oracle Corporation (Director · Since at least May 31, 2018); Akamai Technologies, Inc. (Director · Dec 31, 2017 – May 20, 2018 · Past) | Director · Apr 1, 2019 – Jun 14, 2022 · Past |
| William Huyett Other companies: Rockley Photonics Holdings Ltd (Director · Aug 11, 2021 – May 17, 2022 · Past); Ironwood Pharmaceuticals, Inc. (Chief Operating Officer · Dec 15, 2017 – Apr 1, 2019 · Past) | Chief Financial Officer · Mar 14, 2019 – Nov 6, 2020 · Past |
| Andreas Busch Other companies: Absci Corporation (Chief Innovation Officer · Since at least Mar 17, 2022) | Chief Scientific Officer · Apr 29, 2019 – Jan 20, 2022 · Past |
| Andrew Gottesdiener Other companies: Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023) | Director · Since at least Apr 1, 2026 |
| Cheryl Gault Other companies: Rapport Therapeutics, Inc. (Chief Operating Officer · Since at least Jun 6, 2024) | Chief Operating Officer · Jan 1, 2021 – Jan 20, 2022 · Past |
| Mark G Currie Other companies: Ironwood Pharmaceuticals, Inc. (Director · Since at least Jan 4, 2016) | President and CSO · Apr 1, 2019 – Dec 28, 2020 · Past |
| Michael Mendelsohn Other companies: Foghorn Therapeutics Inc. (Founder, Board Director, & Chief Strategy Officer, Cardurion Pharmaceuticals · Since at least Oct 22, 2020) | Director · Apr 1, 2019 – Jun 14, 2022 · Past |
| Nimish Shah Other companies: Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023) | Director · Since at least Apr 1, 2026 |
| Rhonda M Chicko Other companies: Scholar Rock Holding Corporation (Chief Financial Officer · May 23, 2018 – Jan 31, 2019 · Past) | Chief Financial Officer · Since at least Mar 4, 2024 |
| Stephanie Lovell Other companies: TransMedics Group, Inc. (Director · Since at least Mar 22, 2021) | Director · Apr 1, 2019 – Jun 14, 2022 · Past |
| Angela She | VP, R&D Strategy and Operations · Since at least Nov 4, 2026 |
| Anjeza Gjino | Chief Financial Officer · Jan 1, 2021 – Jan 20, 2022 · Past |
| Dina Katabi | Director · Nov 30, 2023 – Nov 30, 2023 · Past |
| Eva Stroynowski | VP, Investor Relations · Since at least Nov 4, 2026 |
| Gan Wei | Chief Technology Officer · Since at least Nov 4, 2026 |
| Heidi Henson | Director · Since at least Nov 5, 2026 |
| Joshua Park | VP, Protein Sciences · Since at least Nov 4, 2026 |
| Kyle Breidenstine | SVP, Finance · Since at least Nov 4, 2026 |
| Maribel Reyes | VP, Clinical Pharmacology and Translational Science · Since at least Nov 4, 2026 |
| Mark Vignola | Chief Financial Officer · Since at least Nov 4, 2026 |
| Matthew Leoni | Chief Medical Officer · Since at least Nov 4, 2026 |
| Michael Oldham | VP, Clinical Development · Since at least Nov 4, 2026 |
| Michelle Pernice | Director · Since at least Apr 1, 2026 |
| Peter M Hecht | Director · Since at least Jul 16, 2026 |
| Regina Margaret Graul | See Remarks, Director · Since at least Aug 14, 2026 |
| Robin Wojcieszek | SVP, Regulatory, Drug Safety and Medical Writing · Since at least Nov 4, 2026 |
| Vanessa Teachout | VP, Head of Clinical Operations · Since at least Nov 4, 2026 |